GB-1908

N/A

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameGB-1908
Drug Alias NameGB1908GB-1908
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-1 inhibitors
TargetsGalectin-1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalecto Biotech AB
China Registration ClassN/A

Develop Information

Active CompaniesGalecto Biotech AB
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A